Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01564251 |
Title | A Study of GDC-0575 Alone And in Combination With Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Genentech, Inc. |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | FRA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Yale Cancer Center | New Haven | Connecticut | 06520 | United States | Details | |
Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73104 | United States | Details | |
The Sarah Cannon Research Inst | Nashville | Tennessee | 37203 | United States | Details | |
Institut Bergonie; Oncologie | Bordeaux | 33076 | France | Details | ||
Institut Gustave Roussy; Departement Oncologie Medicale | Villejuif | 94805 | France | Details |